GEM3: A multi-centre double-blind placebo-controlled randomised trial of a combination of methotrexate and gefitinib versus methotrexate alone as a treatment for ectopic pregnancy

Project Details

Short titleGEM3: A multi-centre double-blind placebo-controlled randomised trial of a combination of methotrexate and gefitinib versus methotrexate alone as a treatment for ectopic pregnancy
StatusFinished
Effective start/end date1/04/16 → 30/09/19

Funding

  • NIHR EVALUATION, TRIALS AND STUDIES COORDINATING CENTRE